Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$4.71 - $5.92 $43,072 - $54,138
9,145 Added 0.64%
1,435,366 $7.03 Million
Q2 2021

Aug 16, 2021

SELL
$5.32 - $6.53 $130,925 - $160,703
-24,610 Reduced 1.7%
1,426,221 $7.8 Million
Q1 2021

May 17, 2021

BUY
$2.75 - $6.57 $3.99 Million - $9.53 Million
1,450,831 New
1,450,831 $7.73 Million
Q4 2020

Feb 16, 2021

SELL
$1.38 - $3.01 $2.73 Million - $5.95 Million
-1,977,965 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$1.58 - $4.77 $6.37 Million - $19.2 Million
-4,031,217 Reduced 67.08%
1,977,965 $3.42 Million
Q2 2020

Aug 14, 2020

BUY
$3.74 - $6.28 $965,881 - $1.62 Million
258,257 Added 4.49%
6,009,182 $26.4 Million
Q1 2020

May 15, 2020

BUY
$2.33 - $12.98 $2.93 Million - $16.3 Million
1,255,365 Added 27.92%
5,750,925 $22.5 Million
Q4 2019

Feb 14, 2020

BUY
$6.75 - $11.15 $4.76 Million - $7.87 Million
705,529 Added 18.62%
4,495,560 $48.1 Million
Q3 2019

Nov 14, 2019

BUY
$8.57 - $10.72 $828,753 - $1.04 Million
96,704 Added 2.62%
3,790,031 $32.6 Million
Q2 2019

Aug 14, 2019

SELL
$7.58 - $10.0 $449,084 - $592,460
-59,246 Reduced 1.58%
3,693,327 $30.4 Million
Q1 2019

May 15, 2019

BUY
$5.81 - $9.37 $1.18 Million - $1.9 Million
202,882 Added 5.72%
3,752,573 $28.9 Million
Q4 2018

Feb 14, 2019

BUY
$5.75 - $21.85 $3.09 Million - $11.7 Million
536,743 Added 17.81%
3,549,691 $22.8 Million
Q3 2018

Nov 14, 2018

BUY
$16.81 - $24.58 $8.16 Million - $11.9 Million
485,565 Added 19.21%
3,012,948 $67.7 Million
Q2 2018

Aug 14, 2018

BUY
$18.6 - $24.94 $9.41 Million - $12.6 Million
505,721 Added 25.02%
2,527,383 $48.8 Million
Q1 2018

May 15, 2018

BUY
$20.86 - $26.6 $291,581 - $371,814
13,978 Added 0.7%
2,021,662 $46.6 Million
Q4 2017

Feb 14, 2018

BUY
$20.9 - $49.36 $20.4 Million - $48.2 Million
977,491 Added 94.88%
2,007,684 $49.4 Million
Q3 2017

Nov 14, 2017

BUY
$39.62 - $46.17 $40.8 Million - $47.6 Million
1,030,193
1,030,193 $43.7 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $131M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.